INSTEAD OF FALLING OFF THE CLIFF WE STARTED GOING UP THE MOUNTAIN..!
Mike, nice post! Relative posts like this deserve their own thread.
Hope you're right about the system wide Fres adoption. We might also hear some news regarding Europe approval this year... I'm not sure what AFFY will charge for their drug considering it is only administered once monthly versus AMGEN's 13x per month. It's one sale per month versus 13 sales per month, however they accomplish the same thing for the patients. Based on this I would hope one doseage of omontys is significantly higher in cost than one doseage of Epogen. And being in the medical insurance field I know Epogen is VERY expensive. Any insight on Omonty pricing would be appreciated.